Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Tharimmune ( (THAR) ) has provided an announcement.
On October 10, 2025, Tharimmune, Inc. filed a Certificate of Amendment with the Secretary of State of Delaware to increase its authorized shares of Common Stock from 250 million to 1 billion. This significant increase in authorized shares could potentially impact the company’s operations and market positioning by providing more flexibility for future financing and growth opportunities.
The most recent analyst rating on (THAR) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Tharimmune stock, see the THAR Stock Forecast page.
More about Tharimmune
Average Trading Volume: 10,003,935
Technical Sentiment Signal: Hold
Current Market Cap: $17.51M
See more data about THAR stock on TipRanks’ Stock Analysis page.